Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...
STAT13d
Pharmalittle: We’re reading about a Merck drug-label controversy, Astellas pulling an application, and more
A drug against fungal infections in cancer patients can last twice as long in people with obesity, and may make chemotherapy ...
The Globe and Mail3d
Canada's Drug Agency Recommends WINREVAIR® (sotatercept) for Reimbursement
KIRKLAND, QC, Nov. 8, 2024 /CNW/ - Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced that Canada's Drug Agency (CDA ... inhibitor therapy for PAH in Canada, a new ...
C&EN3d
Services companies invest in antibody-drug conjugates
MilliporeSigma, the North American drug services arm of Merck KGaA, says it will invest $76 million to manufacture ADCs for ...
Merck Says Winrevair Recommended for Reimbursement in Canada
Merck & Co. said Friday that Canada's Drug Agency recommended the company's Winrevair for reimbursement as a treatment for adults with pulmonary arterial hypertension. The agency recommended the ...
NBC 10 Philadelphia11d
Merck tops earnings estimates on strong demand for Keytruda, new drugs even as HPV vaccine sales fall
But Merck has a handful of new deals under its belt and key drug launches that will help it offset those losses. That includes Winrevair, a medication approved in the U.S. in March to treat a ...